Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
09/2002
09/25/2002CN1371374A Substituted heterocycle fused gamma-carbolines
09/25/2002CN1371279A Metabolites of ecteinascidin 743
09/24/2002US6455703 1,3,6,-Trihydro-6-aza-3-oxapentalen-2-one derivatives for the treatment of neoplasia
09/24/2002US6455699 Camptothecin analogs and methods of preparation thereof
09/24/2002US6455579 Useful in photochemical polymerization, dye laser, and electroluminescence.
09/24/2002US6455534 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
09/24/2002US6455527 High affinity ligands for nociceptin receptor ORL-1
09/24/2002US6455525 Heterocyclic substituted pyrazolones
09/24/2002US6455523 Inhibitors of farnesyl protein transferase
09/24/2002US6455519 Use of substituted N, N-disubstituted fused-heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity
09/19/2002WO2002073208A2 Anti-epileptogenic agents
09/19/2002WO2002072587A1 Antidepressant azaheterocyclymethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoline
09/19/2002WO2002072582A1 Methods for the synthesis of densely functionalized pyrrolidine template libraries
09/19/2002WO2002072550A1 Substituted dimethyl-[1-(1-phenyl-cyclohexyl)-piperidin-3-yl methyl]-amines and the use of the same as analgesics
09/19/2002WO2002072549A1 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
09/19/2002WO2002072085A1 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
09/19/2002WO2002053534A8 Vla-4 inhibitors
09/19/2002WO2002026730A3 Fluorinated quinolones as antimitotic and antitumor agents
09/19/2002WO2002014311A3 Urea compounds and methods of uses
09/19/2002US20020132827 Using full D1 dopamine receptor agonists in an intermittent dosing protocol with a short, but essential, "off-period."
09/19/2002US20020132820 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
09/19/2002DE10112198A1 Substituierte Dimethyl-[1-(1-phenyl-cyclohexyl)-piperidin-3-ylmethyl]-amine Substituted dimethyl- [1- (1-phenyl-cyclohexyl) -piperidin-3-ylmethyl] -amines
09/19/2002CA2440834A1 Anti-epileptogenic agents
09/19/2002CA2440758A1 Substituted dimethyl-[1-(1-phenyl-cyclohexyl)-piperidin-3-ylmethyl]-amines
09/19/2002CA2440555A1 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
09/18/2002EP1240160A1 Substituted pyridazines having cytokine inhibitory activity
09/18/2002EP1000034B1 Substituted 6-alkylphenanthridines
09/18/2002EP0944386B1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
09/18/2002EP0889886B1 Novel phenanthridines substituted in the 6 position
09/18/2002EP0837847B1 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides
09/18/2002EP0804427B1 Lta4 hydrolase inhibitors
09/18/2002EP0764158B1 Benzopyrans and their use as therapeutic agents
09/18/2002CN1370176A Subsstituted heterocycle fused gamma-carbolines
09/18/2002CN1370174A 2,3-benzodiazepine derivatives
09/18/2002CN1370173A Isomeric fused pyrrolocarbazoles and isoindolones
09/18/2002CN1370169A Substituted heterocycle fused gamma-carbolines
09/18/2002CN1370168A Novel spiro compounds
09/18/2002CN1370144A Aromatic sulfone hydroxamic acid metalloprotease inhibitor
09/18/2002CN1370046A Fungicides
09/17/2002US6452000 Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate
09/17/2002US6451843 Arylphenyl-substituted cyclic keto enols
09/17/2002US6451830 Use of substituted N,N-disubstituted non-fused heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity
09/17/2002US6451823 Use of substituted N-phenoxy-N-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
09/17/2002US6451816 Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression
09/17/2002US6451776 Water soluble prodrugs of hindered alcohols
09/12/2002WO2002070567A1 Novel compound, process for producing the same, and use thereof as support for solid-phase reaction
09/12/2002WO2002070541A2 Peptide deformylase inhibitors
09/12/2002WO2002070525A2 Nitrogen-based camptothecin derivatives
09/12/2002WO2002070511A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
09/12/2002WO2002070486A1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity
09/12/2002WO2002070481A1 Hydroxy-substituted n-alkoxy hindered amines and compositions stabilized therewith
09/12/2002WO2002070469A2 Selective pde3b inhibitors and use of the same in therapy
09/12/2002WO2002069895A2 Heterocyclic analgesic compounds and methods of use thereof
09/12/2002WO2001074339A3 A use of galantamine for the treatment of neuropsychiatric behaviour associated with alzheimer's disease
09/12/2002US20020128263 Treatment or prevention of mGluR5 receptor mediated disorders.
09/12/2002US20020128262 Styrylbenzodiazepines
09/12/2002US20020127366 Singly recordable compact disc (CD-R)
09/12/2002CA2439827A1 Peptide deformylase inhibitors
09/12/2002CA2439666A1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity
09/12/2002CA2437594A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
09/11/2002EP1238979A1 Fused heterotricyclic compounds, process for preparing the compounds and drugs containing the same
09/11/2002EP1237524A2 Analogs of galanthamine and lycoramine as modulators of nicotinic receptors
09/11/2002EP0934309B1 New pyridyl alkane acid amides as cytostatics and immunosuppressives
09/11/2002CN1368848A Heterocyclic spiro compounds as pesticides
09/11/2002CN1090634C Pro-drugs and counterparts of camptothecin, their application as medicines
09/11/2002CN1090627C 2-amino-1,2-indene compounds, process for their preparation and pharmaceutical compositions containing them
09/11/2002CN1090617C Pyrole derivatives and medicinal composition
09/10/2002US6448405 Coupling a 2-halo-5-nitrobenzoic acid and a 2-methoxyphenyl boronic acid; cyclizing to a nitrobenzocoumarin; reducing to the amine; converting to a coumarino(3,4-f)quinoline; reduction to a 5h-chromeno(3,4-f)quinoline
09/10/2002US6448295 Treating cardiovascular disease; atherosclerosis, dyslipidema hypercholesterolaemia; decreasing concentrations of low density lipoprotein and raising level of high density lipoprotein
09/10/2002US6448250 Sulfamato hydroxamic acid metalloprotease inhibitor
09/10/2002US6448248 Heterocyclic carboxylic acid derivatives, the production and use thereof as endothelin receptor antagonists
09/10/2002US6448247 Tachykinin receptor antagonist; especially to the receptors for substance p (which receptors are generally referred to as ?neurokinin 1 receptors?)
09/10/2002US6448243 Serotonin antagonist for treating, ameliorating and preventing spastic paralysis or central muscle relaxants for ameliorating myotonia
09/10/2002CA2195129C Substituted piperidine intermediates for producing heterocyclic-cyclic amine derivatives capable of inhibiting cholinesterase
09/06/2002WO2002068415A1 Pyrazole compounds useful as protein kinase inhibitors
09/06/2002WO2002068388A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists
09/06/2002WO2002068387A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists
09/06/2002WO2002038563A3 Condensed pyrazindione derivatives as pde inhibitors
09/06/2002WO2002022577A3 Hydroxamate derivatives useful as deacetylase inhibitors
09/06/2002WO2002008475A3 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
09/04/2002EP1236729A1 Clavulanic acid aldehyde, beta-lactamase inhibitor
09/04/2002EP1236728A2 S-type 2-substituted hydroxy-2-indolinylbutyric ester compounds and process for preparation thereof
09/04/2002EP1235825A1 Novel benzoimidazole derivatives useful as antiproliferative agents
09/04/2002EP1235803A1 Urea compounds having muscarinic receptor antagonist activity
09/04/2002EP1235802A1 Carbamate derivatives having muscarinic receptor antagonist activity
09/04/2002EP1235595A2 Integrin-mediated drug targeting
09/04/2002EP1036076B1 Novel compounds
09/04/2002EP0847397B1 water-soluble c-ring analogues of 20 (s)-camptothecin
09/04/2002EP0830348B1 Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
09/04/2002EP0775143B1 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments
09/04/2002CN1367694A Camptothecin analogs and methods of preparation thereof
09/04/2002CN1090190C Heterocycle-condensed morphinoid derivatives and its preparing method and use
09/04/2002CN1090189C Pyrazolopyrimidines type compound
09/03/2002US6444823 Pyridyl alkane acid amides as cytostatics and immunosuppressives
09/03/2002US6444820 Process for the manufacture of camptothecin derivatives
09/03/2002US6444812 Intermediate compounds in the preparation of farnnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N-or C linked imidazoles
09/03/2002US6444811 Central nervous system disorders; cardiovascular disorders
09/03/2002US6444672 Heterocyclic derivatives and their use as antithrombotic agents
09/03/2002US6444617 Preemergent and postemergent herbicides
08/2002
08/29/2002WO2002066475A2 Tricyclic androgen receptor modulator compounds